ovel strategies in weight loss in women with polycystic ovary syndrome: does the gut microbiome play a role?

niversity Hospital Leuven0 个研究点目标入组 60 人开始时间: 2018年3月29日最近更新: 2024年3月4日

适应症

试验速览

暂无简介。

•Women aged between 18 and 40 years, with PCOS presenting anovulation, hyperandrogenism and polycystic ovarian morphology and who are at risk for metabolic syndrome:
•oBMI = 27 kg/m2 and one of the risk factors of metabolic syndrome according to the International Diabetes Federation (IDF) consensus worldwide definition of the metabolic syndrome 2006
•oBMI = 30 kg/m2
•and who have no known inflammatory bowel disease or auto-immune disease
•and who have access to a -20°C freezer
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 60
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range

•women will be excluded from participation in case of:
•-pregnancy
•-use of oral contraceptive pill
•-use of immunomodulatory drugs, antidiabetic drugs or anti-inflammatory drugs on a daily basis
•-inflammatory bowel disease, autoimmune disease
•-(medical history of) pancreatitis

发起方

niversity Hospital Leuven